News | Radiopharmaceuticals and Tracers | September 11, 2015

Zevacor Installs First Medical-only 70 MeV Cyclotron in U.S.

Cyclone 70 to stabilize U.S. supply of Strontium 82, produce next generation of radiopharmaceutical products

Zevacor, IBA, 70 MeV cyclotron, Cyclone 70P, radiopharmaceuticals

September 11, 2015 — Zevacor Molecular (Zevacor), manufacturer and distributor of positron emission tomography (PET) and single photon emission computed tomography (SPECT) radiopharmaceuticals, announced the arrival of a 70 MeV Cyclotron at its new production facility in Noblesville, Indiana.

The 140-ton Cyclone 70P, manufactured in Belgium by Ion Beam Applications S.A (IBA), is the first commercial 70 MeV cyclotron dedicated to medical use in the United States. Expected to be fully operational in the first quarter of 2016, the cyclotron is being installed in a new, state-of-the-art high capacity manufacturing center. The center will house a complement of radioisotope synthesis equipment able to produce a broad range of radiopharmaceuticals for clinical and research applications.

The initial primary focus of the 70 MeV cyclotron will be the commercial manufacture of Strontium 82 to ensure an ample, stable U.S.-based supply of Strontium 82/Rubidium 82 generators for use in the diagnosis of cardiovascular disease. The cyclotron will also be employed to produce a wide variety of other radionuclides for both research and clinical applications.

The Cyclone 70P is an optimized, high-power proton cyclotron with variable proton acceleration in the energy range of 30 to 70 MeV. The 140-ton unit has two ports, six beam lines and capabilities for solid, liquid and gas targets.

For more information: www.iba-worldwide.com

Related Content

Siemens Healthineers Announces First U.S. Install of Somatom go.Top CT
News | Computed Tomography (CT) | September 17, 2018
September 17, 2018 — The Ohio State University Wexner Medical Center in Columbus recently became the first healthcare
Lightvision near-infrared fluorescence imaging system
News | Women's Health | September 11, 2018
Shimadzu Corp.
The Siemens Biograph Vision PET-CT system was released in mid-2018.

The Siemens Biograph Vision PET-CT system was released in mid-2018.

Feature | Nuclear Imaging | September 07, 2018 | By Dave Fornell
Nuclear imaging technology for both single photon emission computed tomography (SPECT) and positron emission tomography...
PET Imaging Agent Predicts Brain Tau Pathology, Alzheimer's Diagnosis
News | PET Imaging | September 05, 2018
Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced a Phase 3 study of positron emission tomography (PET)...
Rapid Cardiac MRI Technique May Cut Costs, Boost Care in Developing World
News | Magnetic Resonance Imaging (MRI) | August 29, 2018
A newly developed rapid imaging protocol quickly and cheaply diagnosed heart ailments in patients in Peru, according to...
Brain Study of 62,454 Scans Identifies Drives of Brain Aging
News | SPECT Imaging | August 27, 2018
In the largest known brain imaging study, scientists from five institutions evaluated 62,454 brain single photon...
Abnormal Protein Concentrations Found in Brains of Military Personnel With Suspected CTE

Researchers are using the tracer, which is injected into a patient, then seen with a PET scan, to see if it is possible to diagnose chronic traumatic encephalopathy in living patients. In this image, warmer colors indicate a higher concentration of the tracer, which binds to abnormal proteins in the brain. Credit UCLA Health.

News | PET Imaging | August 24, 2018
August 24, 2018 — In a small study of
Philips Launches Epiq CVx and CVxi Cardiovascular Ultrasound Systems
Technology | Cardiovascular Ultrasound | August 22, 2018
Philips recently announced the introduction of the Epiq CVx cardiovascular ultrasound system. Built on the Epiq...
Videos | Magnetic Resonance Imaging (MRI) | August 13, 2018
Haojie Wang, M.D., director of advanced cardiovascular MRI and a member of the heart valve clinic at Baylor Scott Whi
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
Overlay Init